Rafferty Asset Management, LLC Relay Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$29.7 Billion
Q3 2025

A detailed history of Rafferty Asset Management, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 151,575 shares of RLAY stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

151,575

Previous 181,957 16.7%

Holding current value

$1 Million

Previous $629,000 25.76%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$3.22 - $5.22 $97,830 - $158,594	-30,382 Reduced 16.7%	151,575 $791,000
Q2 2025 Aug 14, 2025	SELL	$2.0 - $3.49 $46,222 - $80,657	-23,111 Reduced 11.27%	181,957 $629,000
Q1 2025 May 14, 2025	SELL	$2.62 - $4.92 $116,571 - $218,905	-44,493 Reduced 17.83%	205,068 $537,000
Q4 2024 Feb 14, 2025	BUY	$4.12 - $6.8 $286,467 - $472,810	69,531 Added 38.62%	249,561 $1.03 Million
Q3 2024 Nov 13, 2024	SELL	$6.23 - $9.51 $86,609 - $132,208	-13,902 Reduced 7.17%	180,030 $1.27 Million

Q2 2024 Aug 13, 2024	SELL	$5.9 - $8.02 $1.59 Million - $2.17 Million	-270,128 Reduced 58.21%	193,932 $1.26 Million
Q1 2024 May 13, 2024	BUY	$7.5 - $12.07 $1.02 Million - $1.65 Million	136,512 Added 41.68%	464,060 $3.85 Million
Q4 2023 Feb 13, 2024	SELL	$6.01 - $11.48 $301,683 - $576,261	-50,197 Reduced 13.29%	327,548 $3.61 Million
Q3 2023 Nov 13, 2023	SELL	$8.24 - $12.97 $2.05 Million - $3.23 Million	-249,268 Reduced 39.75%	377,745 $3.18 Million
Q2 2023 Aug 11, 2023	BUY	$9.99 - $18.27 $1.83 Million - $3.35 Million	183,387 Added 41.34%	627,013 $7.88 Million
Q1 2023 May 11, 2023	SELL	$15.0 - $22.76 $459,795 - $697,662	-30,653 Reduced 6.46%	443,626 $7.31 Million
Q4 2022 Feb 13, 2023	BUY	$14.16 - $24.02 $3.94 Million - $6.68 Million	278,160 Added 141.83%	474,279 $7.09 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $253,359 - $439,838	14,021 Added 7.7%	196,119 $4.39 Million
Q2 2022 Aug 12, 2022	BUY	$13.31 - $34.88 $157,377 - $412,421	11,824 Added 6.94%	182,098 $3.05 Million
Q1 2022 May 13, 2022	SELL	$20.26 - $32.36 $399,689 - $638,398	-19,728 Reduced 10.38%	170,274 $5.1 Million
Q4 2021 Feb 10, 2022	BUY	$26.0 - $37.03 $2.42 Million - $3.44 Million	92,906 Added 95.68%	190,002 $5.84 Million
Q3 2021 Nov 10, 2021	BUY	$29.75 - $37.99 $620,912 - $792,889	20,871 Added 27.38%	97,096 $3.06 Million
Q2 2021 Aug 10, 2021	SELL	$27.5 - $38.19 $236,060 - $327,822	-8,584 Reduced 10.12%	76,225 $2.79 Million
Q1 2021 May 10, 2021	BUY	$32.52 - $61.53 $2.4 Million - $4.54 Million	73,840 Added 673.17%	84,809 $2.93 Million
Q4 2020 Feb 10, 2021	BUY	$35.51 - $54.03 $389,509 - $592,655	10,969 New	10,969 $456,000

Others Institutions Holding RLAY

# of Institutions

215

Shares Held

168M

Call Options Held

714K

Put Options Held

14.9K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $796M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Relay Therapeutics, Inc. Transaction History